TxCell amends IPO

TxCell S.A., Valbonne, France Business: Autoimmune Date announced: 3/31/14 Type: IPO To be raised: Up to €26.4 million ($36.3 million) Shares: 3.9 million Price: €5.58 - €6.82 Overallotment: 667,741 N...